Don’t miss the latest developments in business and finance.

HBL to launch six animal vaccines for large animals

Image
BS Reporter Mumbai/ Ahmedabad
Last Updated : Jan 21 2013 | 4:10 AM IST

Ahmedabad-based Hester Biosciences Limited (HBL) will commercially launch as many as half a dozen vaccines for large animals within six months.

The production of these vaccines will be done in the company's manufacturing plant in Kadi block of Mehsana district.

The BSE-listed company has obtained the technology to manufacture the vaccines, by signing a technology transfer agreement with Indian Veterinary Research Institute (IVRI). Besides production it will also be marketing it in the Indian market.

"Emerging animal diseases have always been a threat which needs to be addressed. We will be launching commercially, in next six months, vaccines for common diseases found in Indian cattle and sheep. This would included vaccine for Peste des petits ruminants (PPR), which will be part of the national disease eradication program embarked by the Government of India," CEO & MD of HBL Rajiv Gandhi said.

"We have acquired technology for manufacture from IVRI and would be marketing the vaccines for various diseases across the country," he said.

The diseases for which HBL would be manufacturing vaccine includes PPR a highly contagious and infectious viral disease of domestic and wild small ruminants, goat pox, sheep pox, Theileria, Haemorrhagic septicaemia (HS), Black quarter (BQ), Brucella.

More From This Section

HBL's projected production of vaccine for PPR, goat pox, sheep pox, HS, BQ, is 20 million units per annum, while for Theileria and Brucella vaccines it projection was two million units each per annum.

The company has set up a Joint Venture in Nepal to manufacture a specific range of large animal biologicals. Its project size is Rs 15 crore.

The unit is an export oriented and is slated to go on-stream by March 2013.

Gandhi said that after the unit commences production they would be manufacturing 160 million units of PPR vaccine which would be exported to Nigeria, Sudan, Pakistan, Iran, Ethiopia and east Asian countries.

He further said that 60 million units of Classical swine fever vaccines would also be manufactured from the Nepal unit for export to south east Asia.

Also Read

First Published: May 18 2012 | 12:26 AM IST

Next Story